DI PALMA, Martina et al. Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 14, n. 1, p. e2022043, 2022. DOI: 10.4084/MJHID.2022.043. Disponível em: https://www.mjhid.org/mjhid/article/view/4979. Acesso em: 22 dec. 2024.